Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Nanomedicine

A literature review was conducted between 10 and 16 September 2021, about all expressions unsing the prefix “nano” and selecting the results related to health or medicine, in English and in French, in the following databases: Dalloz, Lextenso, HeinOnline, Lexis Nexis, Navis, Lexbase, Cairn, Westlaw, Brill and Doctrinal Plus. Please find below the most relevant results of this review.

Azoulay, David, and Vito Buonsante. ‘Regulation of Nanomaterials in the EU: Proposed Measures to Fill in the Gap Reports: Nanotechnology’. European Journal of Risk Regulation (EJRR) 5, no. 2 (2014): 228–35.

Bensaude-Vincent, Bernadette, and Vanessa Nurock. ‘Éthique des nanotechnologies’. In Traité de bioéthique. Érès, 2010. http://www.cairn.info/traite-de-bioethique-1–9782749213057-page-355.htm.

Bensaude-Vincent, Bernadette, and Jonathan Simon. ‘Introduction. Nanotechnoscience: The End of the Beginning’. Philosophia Scientiae 23–1, no. 1 (2019): 5–17.

Bernard, Daniel. ‘La terminologie des nanotechnologies au cœur des processus normatifs’. Annales des Mines – Realites industrielles Février 2010, no. 1 (2010): 48–53.

Best, Robert, and George Khushf. ‘The Social Conditions for Nanomedicine: Disruption, Systems, and Lock-in Symposium Article’. Journal of Law, Medicine and Ethics 34, no. 4 (2006): 733–40.

Borghi, Elsa, Patricia Saïd, Agnès Pottier, and Laurent Lévy. ‘Les nanoparticules thérapeutiques : une voie novatrice pour la radiothérapie appliquée à la cancérologie’. Annales des Mines – Realites industrielles Février 2010, no. 1 (2010): 39–47.

Browaeys, Dorothée Benoit. ‘Nanotechnologies : réguler l’incertain’. Etudes Tome 415, no. 11 (4 November 2011): 451–62.

Brownsword, Roger. ‘Human Dignity and Nanotechnologies: Two Frames, Many Ethics On Medical Ethics’. Jahrbuch Fur Recht Und Ethik 19 (2011): 429–40.

Byk, Christian. ‘Chapitre 10. Nanomaterials and the environmental risk: is there some room left for ethics and law?’ Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 157–72.

Calliess, Christian, and Heidi Stockhaus. ‘Precautionary Principle and Nanomaterials: REACH Revisited’. Journal for European Environmental & Planning Law 9, no. 2 (1 January 2012): 113–35. https://doi.org/10.1163/187601012X639817.

Campolini, Manuel. ‘Protection of Innovative Medicinal Products and Registration of Generic Products in the European Union: Is the Borderline Shifting? State of Play and the Proposed European Medicine Legislation’. European Intellectual Property Review (EIPR) 25, no. 2 (2003): 91–97.

Castillo, Aida Maria Ponce Del. ‘La réglementation européenne en matière de nanotechnologies’. Courrier hebdomadaire du CRISP n° 2065, no. 20 (8 July 2010): 5–40.

Chauveau, Sophie. ‘Sidi-Boumédine, Farid: L’invention d’un Médicament. Pratiques, Relations et Communications de Scientifiques à La Recherche d’une Nanoparticule Contre Le Cancer. Paris, Presses Universitaires de France, 2015. 272 p. (Partage Du Savoir 1). € 25.–. ISBN 978-2-13-063532-1 (e-Book Disponible)’. Gesnerus 74, no. 1 (6 November 2017): 149–50. https://doi.org/10.1163/22977953-07401018.

Chéenne, Patrick. ‘La maîtrise du risque « nano », enjeu majeur pour l’industrie européenne. Une approche d’entrepreneurs’. Annales des Mines – Realites industrielles Février 2010, no. 1 (2010): 63–67.

Coppens, Patrick, and Francesco Planchenstainer. ‘The Labelling of Nanomaterials under EU Law, with a Particular Focus on France’. European Food and Feed Law Review (EFFL) 14, no. 2 (2019): 152–59.

Doucet, Maud. ‘Chapitre 11. L’obligation de sécurité de l’employeur et les nanomatériaux’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 173–84.

Drais, Éric. ‘La Prévention Des Risques Émergents à l’épreuve Du Principe de Précaution : Le Cas Des Nanomatériaux’. Droit et Société 96 (1 May 2017): 305–19.

D’Silva, Joel. ‘Pools, Thickets and Open Source Nanotechnology.’ European Intellectual Property Review (EIPR) 31, no. 6 (2009): 300–306.

D’Silva, Joel, and Geert van Calster. ‘Taking Temperature – A Review of European Union Regulation in Nanomedicine News & Views’. European Journal of Health Law 16, no. 3 (2009): 249–70.

Dupont, Jean-Claude. ‘La psychiatrie est-elle soluble dans les nanobiotechnologies ? Le cas des biomarqueurs’. L’information psychiatrique Volume 97, no. 2 (4 March 2021): 133–40.

Ebbesen, Mette. ‘The Principle of Justice and Access to Nanomedicine in National Healthcare Systems’. Studies in Ethics, Law, and Technology 3, no. 3 (2009): 1–15.

Einsiedel, Edna F., and Greg McMullen. ‘Stakeholders and Technology: Challenges for Nanotechnology’. Health Law Review 12, no. 3 (2004 2003): 5–9.

Faunce, Thomas A. ‘Nanotechnology in Global Medicine and Human Biosecurity: Private Interests, Policy Dilemmas, and the Calibration of Public Health Law Symposium Article’. Journal of Law, Medicine and Ethics 35, no. 4 (2007): 629–42.

Fichet, Christophe. ‘Nanotechnologies Dans Le Domaine Médical : Un Remède Face à La Crise En Mal de Réglementation’. Les Petites Affiches 180 (9 September 2009): 3–5.

Foladori, Guillermo, and Noela Invernizzi. ‘A Critical Vision of Disruptive Nanotechnologies’. Perspectives on Global Development and Technology 17, no. 5–6 (11 December 2018): 614–31. https://doi.org/10.1163/15691497-12341497.

Gazagne, Dider. ‘État de l’art de Nanotechnologies et Cadre Juridique Européen et Français (1ère Partie)’. La Gazette Du Palais, no. 113 (23 April 2009): 23.

Guchet, Xavier, and Cécile Legallais. ‘Nanotechnologies et ingénierie du foie bioartificiel. Une autre idée de la « convergence technologique »’. Philosophia Scientiae 23–1, no. 1 (2019): 121–35.

Guèye, Thierno. ‘Les nanotechnologies, par-delà l’« indéfinissabilité »’. Philosophia Scientiae 23–1, no. 1 (2019): 19–37.

Hall, Rebecca M., Tong Sun, and Mauro Ferrari. ‘A Portrait of Nanomedicine and Its Bioethical Implications Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight’. Journal of Law, Medicine and Ethics 40, no. 4 (2012): 763–79.

Hasmin, Nor Akhmal, Zinatul Ashiqin Zainol, Rahmah Ismail, and Anida Mahmood. ‘Regulatory Challenges of Nanofood Labelling’. Journal of Politics and Law 13, no. 2 (2020): 241–49.

Hermerén, Göran. ‘Questions éthiques soulevées par les nanotechnologies’. Annales des Mines – Realites industrielles Février 2010, no. 1 (2010): 74–82.

Hogle, Linda F. ‘Concepts of Risk in Nanomedicine Research Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight’. Journal of Law, Medicine and Ethics 40, no. 4 (2012): 809–22.

———. ‘Science, Ethics, and the Problems of Governing Nanotechnologies Developing Oversight Approaches to Nanobiotechnology: The Lessons of History: III. Cross-Cutting Ideas’. Journal of Law, Medicine and Ethics 37, no. 4 (2009): 749–58.

Huglo, Christian. ‘Les Nano-Technologies Entre Le Droit de l’environnement et Le Droit de La Santé En Attendant Un Droit Européen Spécifique’. Environnement 6 (1 June 2009): 1–2.

Jehl, Joseph. ‘Nanotechnologies : Vers Des Normes Juridiques de l’Europe Des 47 ?’ JCP G Semaine Juridique (Édition Générale) 48 (26 November 2012): 2155–2155.

Johnson, Summer. ‘The Era of Nanomedicine and Nanoethics: Has It Come, Is It Still Coming, or Will It Pass Us by? Editorial’. American Journal of Bioethics 9, no. 10 (2009): 1–2.

Jouzel, Jean-Noël. ‘Chapitre 9. La dose à l’épreuve ? Les enjeux de santé environnementale liés aux nanotechnologies’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 145–55.

Kato, Yutaka. ‘Chapitre 3. The nanotech R&D situation in Japan and ethics of nanotechnology’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 57–69.

Khushf, George, and Ronald A. Siegel. ‘What Is Unique about Nanomedicine: The Significance of the Mesoscale Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight’. Journal of Law, Medicine and Ethics 40, no. 4 (2012): 780–94.

Kimmelman, Jonathan. ‘Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight’. Journal of Law, Medicine and Ethics 40, no. 4 (2012): 841–47.

Lacour, Stéphanie. ‘Chapitre 7. Nanopatents and their impact on the medical environment’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 119–33.

———. ‘L’étiquetage des produits contenant des nanomatériaux : un cadrage juridico-politique de la controverse liée au développement des nanotechnologies’. Droit et société N° 94, no. 3 (2016): 625. https://doi.org/10.3917/drs.094.0625.

———. ‘Nanopatents and Their Impact on the Medical Environment’. Journal de Médecine Légale, Droit Médical, Victimologie, Dommage Corporel 5, no. 6 (1 November 2011): 345–54.

———. ‘Nanotechnologies’. Cahiers Droit Sciences et Technologies 8 (1 June 2019): 213–24.

———. ‘Nanotechnologies’. Cahiers Droit Sciences et Technologies 10 (1 October 2020): 203–22.

———. ‘Nanotechnologies : réguler l’incertitude ?’ Droit et societe n° 78, no. 2 (4 October 2011): 429–46.

Lee, Maria. ‘Risk and beyond: EU Regulation of Nanotechnology’. European Law Review 35, no. 6 (2010): 799–821.

Legros, Bérengère. ‘Nano, Vous Avez Dit Nano? Les Nanotechnologies et Nano-Objets à l’épreuve Des Droits, de La Santé et de l’éthique’. Revue Générale de Droit Médical 60 (1 September 2016): 15–162.

Lepage Corinne. ‘L’urgence d’un Droit Des Nanotechnologies’. La Gazette Du Palais 184, no. 185 (3 July 2009): 3–5.

Lintz, Pascale. ‘Enhancement et nanotechnologies’. Revue d’ethique et de theologie morale n° 286, no. 4 (24 September 2015): 47–59.

Lupton, Michael. ‘The Social, Moral & Ethical Issues Raised by Nanotechnology in the Field of Medicine Bioethics’. Medicine and Law 30, no. 2 (2011): 187–200.

———. ‘Where to Draw the Line – Regulation of Therapeutic Applications of Nanotechnology’. Asian Journal of WTO and International Health Law and Policy 9, no. 1 (2014): 197–216.

Maestrutti, Marina. ‘Chapitre 4. Cyborg identities and contemporary techno-utopias: adaptations and transformations of the body in the age of nanotechnology’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 71–88.

Marchant, Gary E., Blake Atkinson, David Banko, and Joshua Bromley. ‘Big Issues for Small Stuff: Nanotechnology Regulation and Risk Management Symposium: The Biggest Issues for the Smallest Stuff: Nanotechnology Regulation and Risk Management’. Jurimetrics 52, no. 3 (2012 2011): 243–78.

Marchant, Gary E., and Rachel A. Lindor. ‘Prudent Precaution in Clinical Trials of Nanomedicines Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight’. Journal of Law, Medicine and Ethics 40, no. 4 (2012): 831–40.

Marchant, Gary E., and Douglas J. Sylvester. ‘Transnational Models for Regulation of Nanotechnology Symposium Article’. Journal of Law, Medicine and Ethics 34, no. 4 (2006): 714–25.

Marchant, Gary E., Douglas J. Sylvester, and Kenneth W. Abbott. ‘What Does the History of Technology Regulation Teach Us about Nano Oversight?’ Journal of Law, Medicine and Ethics 37, no. 4 (2009): 724–31.

Marchant, Gary E., Douglas J. Sylvester, Kenneth W. Abbott, and Tara Lynn Danforth. ‘International Harmonization of Regulation of Nanomedicine’. Studies in Ethics, Law, and Technology 3, no. 3 (2009): 1–16.

Marks, Jessica L. A., and Shana K. Cyr. ‘Government Regulation of Nanorobots in Medicine: How the FDA and PTO Handle These New Technologies’. RAIL: The Journal of Robotics, Artificial Intelligence & Law 1, no. 4 (2018): 217–30.

Mathew, Thomas. ‘Nanotechnology: An Emerging Area of Scientific Issues and Legal Challenges’. Kathmandu School of Law Review 2 (2013): 81–86.

McGee, Ellen M. ‘Nanomedicine: Ethical Concerns beyond Diagnostics, Drugs, and Techniques Open Peer Commentaries’. American Journal of Bioethics 9, no. 10 (2009): 14–15.

McHale, Jean V. ‘Nanomedicine and the EU: Some Legal, Ethical and Regulatory Challenges Symposium: New Technologies, European Law and Citizens’. Maastricht Journal of European and Comparative Law 16, no. 1 (2009): 65–88.

Meaney, Mark E. ‘Lessons from the Sustainability Movement: Toward an Integrative Decision-Making Framework for Nanotechnology Symposium Article’. Journal of Law, Medicine and Ethics 34, no. 4 (2006): 682–88.

Mehta, Michael D. ‘The Future of Nanomedicine Looks Promising, but Only If We Learn from the Past’. Health Law Review 13, no. 1 (2005 2004): 16–18.

Meyer, Stephan. ‘The EU and Nanotechnologies: A Critical Analysis Book Reviews’. European Journal of Risk Regulation (EJRR) 8, no. 4 (2017): 804–10.

Montfort, Jean-Philippe, Giovanni Indirli, Daniela Georgieva, and Claire-Marie Carrega. ‘Nanomaterials under REACH: Legal Aspects’. European Journal of Risk Regulation 1, no. 1 (2010): 51–62.

Munir, Abu Bakar, and Siti Hajar Mohd Yasin. ‘Nanotechnology in Healthcare: Are Existing Laws Adequate?’ European Journal of Health Law 14, no. 3 (1 January 2007): 261–72. https://doi.org/10.1163/092902707X240611.

Mushiaki, Shigeru. ‘Chapitre 5. Neuroscience and nanotechnologies in Japan – Beyond the hope and hype of converging technologies’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 89–97.

Nelson, Kristen C., David A. Andow, and Michael J. Banker. ‘Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms Developing Oversight Approaches to Nanobiotechnology: The Lessons of History: III. Cross-Cutting Ideas’. Journal of Law, Medicine and Ethics 37, no. 4 (2009): 732–48.

Noury, Mathieu. ‘Chapitre 6. Nanomédecine et médecine personnalisée : appréhender le sens et les défis de la personnalisation du soin à l’heure des technologies moléculaires’. Journal international de bioethique et d’ethique des sciences Vol. 30, no. 1 (7 June 2019): 133–54.

Oftedal, Gry. ‘The Role of “Missile” and “Targeting” Metaphors in Nanomedicine’. Philosophia Scientiae 23–1, no. 1 (2019): 39–55.

Parizeau, Marie-Hélène. ‘Biotechnologie, nanotechnologie, écologie : entre science et idéologie’. Sciences en questions, 2010, 7–66.

Pélisse, Jérôme. ‘Gérer les risques par le droit : articulation et intermédiation dans les laboratoires de nanosciences en France et aux États-Unis’. Droit et societe N° 96, no. 2 (1 September 2017): 321–36.

Poirier, Marie-Sol. ‘L’innovation fondée sur les nanotechnologies au regard de la notion d’acceptabilité sociale de ces développements.’ Master thesis, Sherbrooke University, 2010. https://core.ac.uk/download/pdf/51336936.pdf.

Poirot-Mazères, Isabelle. ‘Chapitre 6. Legal aspects of the risks raised by nanotechnologies in the field of medicine’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 99–118.

———. ‘Médicaments sous forme nanoparticulaire et dispositifs médicaux contenant des nanomatériaux : nouvelle donne pour la balance bénéfice-risque’. Les Actes de la RDUE. Université Toulouse I Capitole, 2018. http://publications.ut-capitole.fr/26180/.

Poirot-Mazères, Isabelle, and Patrick Chaskiel. ‘Chapitre 4. Risques et bénéfices des nanotechnologies médicales : quelle mise en balance ?’ Journal international de bioethique et d’ethique des sciences Vol. 29, no. 2 (27 July 2018): 69–86.

Reichow, Aline. ‘Risk, Uncertainty, and Learning in Nanomaterials Regulation: An Analytical Framework Special Issue on Regulating New and Emerging Technologies’. European Journal of Risk Regulation (EJRR) 7, no. 3 (2016): 502–16.

Salmon, Naomi. ‘What’s Cooking? From GM Food to Nanofood: Regulating Risk and Trade in Europe.’ Environment Law Review 11, no. 2 (2009): 97–115.

Schultz, Amy Couch. ‘Nanotechnology: Industrial Revolution or Emerging Hazard Technical Developments Column’. Environmental Claims Law Journal 19, no. 3 (2007): 199–206.

Schummer, Joachim. ‘Chapitre 2. Cultural diversity in nanotechnology ethics’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 37–55.

Siroux, Danièle. ‘Bioéthique et Droits Des Usagers Du Système de Santé, Note Sous Commentaire de l’avis Du Comité Consultatif National d’éthique Sur Les “Questions Éthiques Posées Par Les Nanosciences, Les Nanotechnologies et La Santé”’. La Gazette Du Palais 157 (6 June 2007): 27–30.

Smismans, Stijn, and Elen Stokes. ‘Innovation Types and Regulation: The Regulatory Framing of Nanotechnology as Incremental or Radical Innovation’. European Journal of Risk Regulation (EJRR) 8, no. 2 (2017): 364–86.

Snir, Reut. ‘Governance by Disclosure: Transnational Convergence in the Field of Nanotechnology’. Transnational Environmental Law 2, no. 1 (2013): 69–94.

Thambisetty, Sivaramjani. ‘The Learning Needs of the Patent System and Emerging Technologies: A Focus on Synthetic Biology’. Intellectual Property Quarterly, no. 1 (2014): 13–19.

Tomoki, Kihira. ‘Chapitre 8. Nanotechnology and environmental ethics’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 135–43.

Ujéda, Louis. ‘Nanotechnology and Synthetic Biology: The Ambiguity of the Nano-Bio Convergence’. Philosophia Scientiae 23–1, no. 1 (2019): 57–72.

Vieu, Christophe, and Bernadette Bensaude-Vincent. ‘Interview de Christophe Vieu, directeur de recherche au LAAS, Toulouse, le 8 décembre 2017’. Philosophia Scientiae 23–1, no. 1 (2019): 161–64.

Vinck, Dominique, and Matthieu Hubert. Nanotechnologies l’invisible révolution. Le Cavalier Bleu, 2017. https://doi.org/10.3917/lcb.vinck.2016.01.

Visciano, Silvia. ‘Chapitre 1. Nanotechnologies, bioethics and human dignity’. Journal International de Bioethique Vol. 22, no. 1 (23 September 2011): 15–36.

Wolf, Susan M., Rishi Gupta, and Peter Kohlhepp. ‘Gene Therapy Oversight: Lessons for Nanobiotechnology Developing Oversight Approaches to Nanobiotechnology: The Lessons of History: I. Case Studies of Oversight Systems’. Journal of Law, Medicine and Ethics 37, no. 4 (2009): 659–84.